drugset / Trial / NCT00847886
Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to evaluate the effect of LX3305 on methotrexate (MTX) pharmacokinetics and to evaluate the safety and tolerability of LX3305 given over 14 days in subjects with stable rheumatoid arthritis that are receiving stable doses of MTX.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LX3305 | Small molecule | — | Oral |
| Subject | Methotrexate | Small molecule | — | — |